8th German Pharm-Tox Summit

Pharmacological inhibition of the small Rho-GTPase Cdc42 reduces the doxorubicin-induced DNA damage response in NIH-3T3 cells

Genotixicity and carcinogenesis	

<B>Posters will be presented during the time period mentioned above. This will give all participants and the poster jury the opportunity to interact with the presenting authors. Please be available to answer questions at your poster during the poster session.  

Christian Henninger

Engagements

07/03/2023